|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02661 QINGSONG HEALTH
Nominal 
5.025 -0.155 (-2.992%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 358,168 | -45.409% | 1,255,887 | 945,006 | 489,961 | 393,607 |
| Cost of Sales | (178,727) | -59.644% | (820,744) | (583,381) | -- | -- |
| Gross Profit | 179,441 | -15.840% | 435,143 | 361,625 | -- | -- |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 375 | -99.309% | (404,658) | (50,418) | (45,088) | (145,834) | |
| Profit / (Loss) on Disposal | -- | -- | -- | 282 | (51) | -- | |
| Other Non-operating Items | -- | -- | (54,126) | (11,969) | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (51,660) | -- | (378,876) | 7,380 | 104,535 | 6,339 | |
| Taxation | 310 | -- | (845) | 1,610 | (7,366) | (15,437) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | 1,408 | (23,553) | 7,004 | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 29 | 33 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (51,350) | -- | (379,721) | 10,398 | 73,645 | (2,061) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (5,048) | 53.341% | (6,575) | (8,914) | (6,363) | 1,904 |
| Depreciation & Amortisation | 2,212 | -3.110% | 4,429 | 4,975 | 4,668 | 5,767 |
| Directors' Emoluments | -- | -- | 8,034 | 6,368 | 6,127 | 6,971 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -25.000 | -- | -458.000 | 13.000 | -- | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.991 | 1.046 | -- | -- |
| NBV per share ($) | 4.472 | -- | 4.856 | -- | -- | -- |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -51,350 |
| %Change | -- |
| EPS / (LPS) | RMB -0.250 |
| NBV Per Share (¥) | RMB 4.472 |